A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer-Reply to letter to the editor by Petelin et al.

[1]  D. Liew,et al.  Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[2]  Charles M Strom,et al.  A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  B. Ward,et al.  BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer , 2009, Cancer.